Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory T cells
Research
Nobel winner turns rogue T cells into their own treatment
By tweaking signaling pathways in the lab, disease-causing T cells were converted into targeted regulatory T cells that suppress inflammation.
Darren Incorvaia
Oct 23, 2025 10:35am
How Nobel-winning cells could become a 'universal drug'
Oct 21, 2025 2:00pm
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am
Edited T cells allow gluten-sensitive mice to eat grains
Mar 20, 2025 7:16am
Coya shares data on IL-2 prospect in small Alzheimer's study
Oct 29, 2024 7:55am
REGiMMUNE, Kiji merge to create Treg 'super company,' plan IPO
Oct 18, 2024 8:05am